Concepedia

Alexander Bloch

AB

Statistics

Publications

62

Citations

2.2K

H-Index

25

Active since

1933

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

New York State Department of Health

Alexander Bloch is an author at Roswell Park Comprehensive Cancer Center specializing in pharmacology, enzyme inhibition, and medicine.

Publications per year

1933–2010

62

Publications

62

Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide or 1-beta-D-arabinofuranosylcytosine.

Ken Takeda, Jun Minowada, Alexander Bloch · PubMed · 1982 · 120 citations

, , +8

Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate.

Ruth W. Craig, Alexander Bloch · PubMed · 1984 · 116 citations

, , +10

Carrying Out a Survey of Refugees: Some Methodological Considerations and Guidelines

Alexander Bloch · Journal of Refugee Studies · 1999 · 109 citations

, , +9

Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.

Richard P. McPartland, Ming C. Wang, Alexander Bloch et al. · PubMed · 1974 · 108 citations

, , +8

Synthesis and biological activity of selected 2,6-disubstituted(2-deoxy-.alpha.- and -.beta.-D-erythro-pentofuranosyl)purines

Leon F. Christensen, Arthur D. Broom, Morris J. Robins et al. · Journal of Medicinal Chemistry · 1972 · 107 citations

, , +11

1–5 of 62